“Nutrition-responsiveness of the immune system: interplay between infectious diseases and diet-related metabolic diseases and the potential for food-based solutions (NUTRIMMUNE)”
In February 2022, JPI HDHL launched a new joint funding activity “Nutrition-responsiveness of the immune system: interplay between infectious diseases and diet-related metabolic diseases and the potential for food-based solutions (NUTRIMMUNE)”.
The interplay of infectious diseases and diet-related metabolic diseases (i.e. non-communicable and communicable diseases) is of emerging importance globally. With new infectious diseases such as COVID-19, which are more severe and more fatal in individuals with obesity or diabetes, the role of co-morbidities in the susceptibility to and severity of infectious disease has become more visible to the public and policy makers. A better understanding of the complex interplay between nutrition, immune function and resilience (including the inflammation component) and human health will enable society to be better prepared for future pandemics and will improve the burden of metabolic diseases.
Aim of the Call
The aim of this call is to support transnational, collaborative research projects that gain a better understanding of the interactions between nutrition and immunity within the context of its interplay between infectious diseases and diet-related metabolic diseases. Research in this area is expected to provide insights that allow the development and scientific substantiation of intervention strategies for sustaining good health through all life stages and treating nutrition-related diseases.
Proposals should focus on one or both of the following topics:
- Establishing the cause-and-effect relationship between nutrition, immune function and infectious diseases in the context of diet-related metabolic disorders.
- Development of innovative food solutions.
|France||French National Research Agency||ANR|
|Germany||Federal Ministry of Education and Research,
(represented by the Project Management Agency in the German Aerospace Center)
|BMBF (represented by DLR)|
|Ireland||Health Research Board||HRB|
|Ireland*||Department of Agriculture, Food and the Marine||DAFM|
|Israel||Ministry of Science and Technology||MOST|
|Italy*||Istituto Superiore di Sanità (National Institute of Health)||ISS|
|Spain||National Institute of Health Carlos III||ISCIII|
|Spain||Research State Agency||AEI|
|The Netherlands||The Netherlands Organisation for Health Research and Development
|ZonMw (Health~Holland represented by ZonMw)|
|UK||Medical Research Council Medical Research Council as part of UK Research and Innovation||UKRI-MRC|
* Did not fund research projects in this call
Weizmann Institute of Science, Israel
|METARYL||Wouter de Jonge
Amsterdam UMC, the Netherlands
Vall d'Hebron Research Institute, Spain
||Maria J Rodríguez-Lagunas
University of Barcelona, Spain
||Quirijn de Mast
Radboud University Medical Center, the Netherlands